Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Genitourinary 1Breast 1

Conditions

Osteosarcoma 7Bone Neoplasms 5Neoplasm Metastasis 4Sarcoma, Ewing 3Sarcoma 3Neuroblastoma 3Rhabdomyosarcoma 2Prostatic Neoplasms 2Pain 2Multiple Myeloma 2Breast Neoplasms 2Bone Diseases 2Spinal Cord Compression 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Renal Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Paraproteinemias 1Osteoporosis 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Nerve Sheath Neoplasms 1Neoplastic Processes 1Neoplasms, Plasma Cell 1Neoplasms 1Myoepithelioma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1

Interventions

glucarpidase 2ripretinib 1gamma-Glutamyl Hydrolase 1Zoledronic Acid 1Methotrexate 1Leucovorin 1Carboxypeptidases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × Zoledronic Acid × Sarcoma × Clear all
NCT00434447 2017-02-27

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Novartis

Phase 4 Completed
73 enrolled
BreastGenitourinaryPlasma cellSarcoma

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡